Default Author • Apr 11, 2022
​In this episode of Life and Life Science, Stephen Gannon speaks to Calum Stevens of BDD pharmaceutical. Calum explains the beneficial division of the business between innovation formulation and clinical development.
BDD Swift clinic accelerates the speed from drug formulation to market, while BDD innovation has amounted to the creation of unrivalled time-release technology. This ‘tab-in-tab’ development can specify medication release times within the body to incredibly tight time profiles. Calum also discusses hopes for the future of BDD, including a Good Manufacturing Practise (GMP) facility.
Check out the video here:
If you would like to find out about the services we provide within Life Sciences recruitment, click here or contact Stephen Gannon today at: Stephen.gannon@kellyservices.com
​
Want to see more? Check out our next episode with Paul Williamson at Realia Marketing.
Kelly UK Tax Strategy
|
Privacy Statement
|
Cookie Policy
|
UK Modern Slavery Transparency Act Statement
|
Human Trafficking Policy
|
Corporate Sustainability Policy
|
Code of Conduct
| Implementation Statement
|
Human Rights Policy
|
Pension Plan Annual Chair's Statement |
Kelly Statement of Investment Principles